Swedish Orphan Biovitrum
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Swedish Orphan Biovitrum
RECRUITINGPhase 4NCT06940830
Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With...
The rationale for this study is to further understand and describe the long-term prophylactic effectiveness of efanesoctocog alfa in preventing joint bleeds in a real-life setting.
Sponsor: Swedish Orphan BiovitrumEnrolling: 25020 locations
Hemophilia A
RECRUITINGPhase 1NCT06579144
Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A
Sobi.BIVV001-003 is an open-label, 2-period, fixed sequence study for intra-participant comparison of the PK profiles of efanesoctocog alfa and the extended half-life rFVIII...
Sponsor: Swedish Orphan BiovitrumEnrolling: 248 locations
Hemophilia A
RECRUITINGPhase 3NCT06716814
Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa
This is a multinational, prospective, open-label, roll-over study in patients with severe haemophilia A, ≥6 years of age, who have completed participation in any of the parental...
Sponsor: Swedish Orphan BiovitrumEnrolling: 10420 locations
Severe Haemophilia A